TBX1 and neoplasm: Within this context, the discovery of the immunogenic properties of Brachyury and the subsequent development of specific CD8+ cytotoxic T-cells able to destroy Brachyury-expressing tumor cells from various cells lines in vitro [130, 180] represent an encouraging step towards the development of Brachyury-targeted therapies.